These data indicated that TTF-1-promoter-operating miR-7 expression might be an ideal strategy in lung cancer, which provided preliminary experimental basis for targeted expression of distinct miRNA in lung cancer and was helpful for the development of gene therapy against clinical lung cancer. Here, TTF1 is linked to lung cancer.